Premium
Immunogenic Dialyzable Factor Derived from a Ribosomal Fraction of Salmonella typhimurium
Author(s) -
Kita Eiji,
Yasui Koichi,
Yasui Kiyoshi,
Matsuda Yasushi,
Matsuda Keiji,
Kashiba Shuzo
Publication year - 1984
Publication title -
microbiology and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 70
eISSN - 1348-0421
pISSN - 0385-5600
DOI - 10.1111/j.1348-0421.1984.tb00736.x
Subject(s) - salmonella , biology , microbiology and biotechnology , immunogenicity , listeria monocytogenes , immunity , antigen , immunization , enterobacteriaceae , salmonella enterica , bacteria , immune system , escherichia coli , immunology , genetics , gene
Dialyzable factors (DF) were prepared from ribosomal fractions of several organisms including rough mutants of Salmonella typhimurium LT2, salmonella species of different serogroups, other enteric bacteria and gram‐positive organisms, and tested for their immunogenicity against S. typhimurium infection in mice. All of them conferred local resistance on mice challenged intramuscularly with S. typhimurium LT2 in the early stage of immunization before the establishment of delayed‐type hypersensitivity (DTH) to salmonella antigens. Although DFs of enteric bacteria including rough mutants of S. typhimurium induced DTH to salmonella antigens, only DF of a two‐heptose mutant of S. typhimurium LT2 afforded significant mouse protection but others only prolonged the mean time to death. DF of Listeria monocytogenes induced the cross‐reacting immunity which afforded the low level of mouse protection as well as an increase in mean time to death without inducing DTH. Passive transfer of anti‐O antibody did not enhance the mouse protection provided by each DF. Resistance conferred by DF of S. typhimurium LT2 consisted of two phases: (i) nonspecific macrophage activation resulting in reduction of organisms at the infected site, which became active in the early stage of immunization and (ii) salmonella‐specific immunity capable of preventing systemic infection, which became active in the late stage of immunization.